Asif Ali - 20 Apr 2026 Form 4 Insider Report for Protagonist Therapeutics, Inc (PTGX)

Reporting relationship: Chief Financial Officer
Issuer ticker: PTGX
Reported as of: 20 Apr 2026
Net transaction value: -$184,572
SEC form: 4
Accepted by SEC: 21 Apr 2026, 16:58:35 UTC
Prior SEC filing: 27 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Matthew Gosling, Attorney-in-Fact for Asif Ali

Key filing fact

Asif Ali filed Form 4 for Protagonist Therapeutics, Inc (PTGX) on 21 Apr 2026.

Key facts

This page summarizes Asif Ali's Form 4 filing for Protagonist Therapeutics, Inc (PTGX).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 21 Apr 2026, 16:58.

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

CIK 0001921163 Primary reporting owner

Relationship: Chief Financial Officer
Address: C/O PROTAGONIST THERAPEUTICS, INC., 7707 GATEWAY BLVD., SUITE 140, NEWARK
Signature: /s/ Matthew Gosling, Attorney-in-Fact for Asif Ali
Signature date: 21 Apr 2026

Shares, units, or other non-derivative securities reported in this filing.

PTGX transaction

Sale

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Explanation of responses 1 footnote

Footnote F1

Sale of shares to cover tax withholding obligation incurred upon settlement of restricted stock units.